It is a scrip offer. The offer is not for 74c. So its MIN Share price / 1300. We are fixed to the share price.
From a liquidity point of view, I would expect a drop in the share price as MIN placed a floor on the price with their offer. So baseline demand is going to be the scrip offer. Though all the same, if you dont care about CGT and really want to take advantage of the offer, it would be better to sell NWE earlier in the piece when MIN were taking advantage off their upwards momentum - this would have garnered you better results than taking on the scrip offer without having to wait for the shares to convert. This probably would have contributed to downward pressure.
I will ignore the NWE share price up until the result of the drills, because then we will see a repricing as the market takes that info into account.
I do have a slight concern CE has already started to threaten us being minority holders, noting that we "will still have to shoulder the burden of their share of significant Perth Basin exploration and development risks."
Im not sure if ASIC's involvement will currently benefit anyone... just if Chris really starts to milk us with these development costs.
- Forums
- ASX - By Stock
- NWE
- ASIC Complaint procedure
ASIC Complaint procedure, page-5
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NWE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online